(1.20%) 5 070.55 points
(0.69%) 38 504 points
(1.59%) 15 697 points
(-0.06%) $83.31
(0.28%) $1.817
(-0.43%) $2 332.00
(-0.41%) $27.25
(0.01%) $922.90
(-0.06%) $0.934
(-0.17%) $10.89
(-0.07%) $0.803
(0.02%) $93.21
Live Chart Being Loaded With Signals
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France...
Stats | |
---|---|
Today's Volume | 38.49M |
Average Volume | 14.22M |
Market Cap | 693 191 |
EPS | €0 ( 2024-02-29 ) |
Next earnings date | ( €0 ) 2024-06-27 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -0.0164 |
ATR14 | €0 (0.00%) |
Volume Correlation
Genomic Vision SA Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Genomic Vision SA Correlation - Currency/Commodity
Genomic Vision SA Financials
Annual | 2022 |
Revenue: | €1.48M |
Gross Profit: | €1.27M (86.01 %) |
EPS: | €-0.0497 |
Q2 | 2023 |
Revenue: | €593 000 |
Gross Profit: | €190 000 (32.04 %) |
EPS: | €-0.0615 |
Q1 | 2023 |
Revenue: | €413 000 |
Gross Profit: | €380 000 (92.01 %) |
EPS: | €-0.0307 |
Q4 | 2022 |
Revenue: | €515 000 |
Gross Profit: | €273 000 (53.01 %) |
EPS: | €-0.0495 |
Financial Reports:
No articles found.
Genomic Vision SA
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators